- Stocks
- Healthcare
- NASDAQ: DRIO

Price (delayed)

$1.225

Market cap

$36.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$32.72M

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software

DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year

DRIO's EPS is up by 29% year-on-year and by 13% since the previous quarter

DarioHealth's gross profit has decreased by 41% YoY and by 12% from the previous quarter

The revenue has declined by 29% year-on-year and by 6% since the previous quarter

What are the main financial stats of DRIO

Market
Valuations
Earnings

Shares outstanding

29.92M

Market cap

$36.66M

Enterprise value

$32.72M

Price to earnings (P/E)

N/A

Price to book (P/B)

0.46

Price to sales (P/S)

2.22

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.72

Revenue

$19.04M

EBIT

-$55.71M

EBITDA

-$50.61M

Free cash flow

-$39.3M

Per share
Balance sheet
Liquidity

EPS

-$1.68

Free cash flow per share

-$1.14

Book value per share

$2.65

Revenue per share

$0.55

TBVPS

$1.62

Total assets

$136.96M

Total liabilities

$58.93M

Debt

$30.44M

Equity

$78.03M

Working capital

$34.71M

Debt to equity

0.39

Current ratio

2.95

Quick ratio

2.67

Net debt/EBITDA

0.08

Margins
Efficiency
Dividend

EBITDA margin

-265.7%

Gross margin

27.6%

Net margin

-282.4%

Operating margin

-323.7%

Return on assets

-52.4%

Return on equity

-84.8%

Return on invested capital

-162.3%

Return on capital employed

-46.7%

Return on sales

-292.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the DarioHealth stock price performed over time

Intraday

1.24%

1 week

-9.26%

1 month

1.24%

1 year

-71.04%

YTD

-28.78%

QTD

2.94%

How have DarioHealth's revenue and profit performed over time

Revenue

$19.04M

Gross profit

$5.25M

Operating income

-$61.64M

Net income

-$53.78M

Gross margin

27.6%

Net margin

-282.4%

DRIO's operating margin has dropped by 62% year-on-year and by 17% since the previous quarter

DarioHealth's gross profit has decreased by 41% YoY and by 12% from the previous quarter

The revenue has declined by 29% year-on-year and by 6% since the previous quarter

The net margin has contracted by 27% YoY but it has grown by 3.3% from the previous quarter

What is DarioHealth's growth rate over time

What is DarioHealth stock price valuation

P/E

N/A

P/B

0.46

P/S

2.22

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

1.72

DRIO's EPS is up by 29% year-on-year and by 13% since the previous quarter

The P/B is 76% lower than the 5-year quarterly average of 1.9 and 54% lower than the last 4 quarters average of 1.0

DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year

DRIO's P/S is 73% below its 5-year quarterly average of 8.0 and 36% below its last 4 quarters average of 3.4

The revenue has declined by 29% year-on-year and by 6% since the previous quarter

How efficient is DarioHealth business performance

DRIO's ROS is down by 32% year-on-year

The ROIC has grown by 24% YoY and by 11% from the previous quarter

DarioHealth's return on equity has decreased by 20% YoY but it has increased by 8% QoQ

DRIO's ROA is up by 12% QoQ but it is down by 7% YoY

What is DRIO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DRIO.

How did DarioHealth financials performed over time

The total assets is 132% greater than the total liabilities

DRIO's total liabilities has surged by 64% year-on-year and by 54% since the previous quarter

The total assets has grown by 42% since the previous quarter and by 27% year-on-year

The debt is 61% less than the equity

DRIO's equity is up by 34% since the previous quarter and by 8% year-on-year

The company's debt to equity fell by 24% QoQ but it rose by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.